Access Program Information
<p>The purpose of this study is to assess the maximum tolerated dose, safety and pharmacokinetics of an investigational drug, intravenous (IV) <strong>Citrulline</strong>, in subjects in steady-state <em>sickle cell disease</em>.</p>